Klin Farmakol Farm. 2011;25(1):24-26

Subclinical thyroid disease

Karolína Drbalová1, Miroslav Vodák1, Václav Zamrazil2
1 ÚVN Praha
2 Endokrinologický ústav Praha

Subclinical thyreopathies are pathological states of the thyroid gland that show no corresponding clinical symptoms, yet may be detected

sporadically by laboratory examination or screening methods. They represent a diagnostic entity, which appeared due to innovations

in laboratory diagnostics and recent focus on pre-clinical stages of manifestative diseases.

Subclinical thyreopathies include subclinical hypothyreosis and hyperthyreosis, thyroid volume or structure changes found accidentally

by sonography, initial stages of malignancy – accidental detection of a micro-carcinoma and subclinical forms of thyroiditis. Controversy

remains concerning exact definition, epidemiological issues, therapeutic intervention, evaluation of risk and gain implied in treatment

of these borderline clinical stages and, last but not least, early screening of risk groups if necessary.

Keywords: subclinical thyroid disease, definition, epidemiology, therapy screening

Published: March 18, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Drbalová K, Vodák M, Zamrazil V. Subclinical thyroid disease. Klin Farmakol Farm. 2011;25(1):24-26.
Download citation

References

  1. Hollowell J, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examinatoion Survey (NHANESIII). J Clin Endocrinol Metab 2002; 87: 489-499. Go to original source... Go to PubMed...
  2. Parle JV, Franklyn JA, Gross KW, Jones SC, Snepard MC. Prevalence and folow-up of abnormal thyrotropin (TSH) contentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf). 1991; 34: 77-83. Go to original source... Go to PubMed...
  3. Duntas LH. Subclinical thyroid disorders: The menace of Trojan horse. J Clin Invest 2003; 36: 472-480. Go to original source... Go to PubMed...
  4. Surks MI, Oritz E, Daniels GH, et al. Subclinical Thyroid Disease. JAMA 2004; 291: 228-238. Go to original source... Go to PubMed...
  5. Tomoda C, Ito Y, Kobayashi K, Miya A, Miyauchi A. Subclinical Hypothyroidism following Hemithyroidectomy: A Simple Risk Scoring Systém Using Age and Preoperative Thyrotropin Level. ORL J Otorhinolaryngol Relat Spec. 2011; 5, 73(2): 68-71. Go to original source... Go to PubMed...
  6. Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid desease prevalence study. Arch Intern Med 2000; 160: 526-534. Go to original source... Go to PubMed...
  7. Zamrazil V. Subklinické tyreopatie. Interní medicína pro praxi 2004; 6: 295-299.
  8. Pluta RM, Burke AE, Glass RM. Subclinical hypothyroidism. JAMA. 2010; 22, 304(12): 1402. Go to original source... Go to PubMed...
  9. Rodondi N, den Elzen WP, Bauer DC. Subclinical hypothyroidism and risk of coronary heart disease and mortality. JAMA. 2010; 22, 304(12): 1365-1374. Go to original source... Go to PubMed...
  10. Földes J, Winkler G. Subclinical hypothyroidism and risk for cardiovascular disease. Are epidemiological studies giving the right answers? Orv Hetil. 2010; 12, 151(37): 1488-1494. Go to original source... Go to PubMed...
  11. Vanderpump MP, Tunbridge WM, French JM, et al. The development of ischemic heart disease in relation to autoimunite thyroid disease in a 20-year follow-up study of an English community. Thyroid 1996; 6: 155-160. Go to PubMed...
  12. Fukata S, Kuma K, Sugawara M. Relationship between cigarettte smoking and hypothyroidism in patiens with Hashimotoś thyroiditis. J Endocrinol Investic 1996; 19: 607-612. Go to original source... Go to PubMed...
  13. Danese MD, Ladenson PW, Meinert CL, Powe NR. Effect of tyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative rewiew of literature. J Clin Endocrinol Metab. 2000; 85: 2993-3001. Go to original source...
  14. Duntas LH. Thyroid Disease and Lipids. Thyroid 2002; 4: 287-293. Go to original source... Go to PubMed...
  15. Mayer Ojr. Je subklinická hypotyreóza rizikovým faktorem kardiovaskulárních chorob? Cor Vasa 2004; 46(3): 123-127.
  16. Lekakis J, Papamichael C, Alevizaki M, Piperingos G, Marafelia P. Flow-mediated, endothelium-dependent vasodilatation is impaird in subjekt with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 1997; 7: 411-414. Go to original source... Go to PubMed...
  17. Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med. 2002; 137: 904-914. Go to original source... Go to PubMed...
  18. Chadarevian R, Bruckert E, Leenhardt L, et al. Components of the fibrinolytic system are differently altered in moderate and severe hypotyroidism. Clin Endocrinol Metab 2001; 86: 732-737. Go to original source... Go to PubMed...
  19. Casey BM, Dashe JS, Wells CE, Mc Intire DD, Byrd W, Leveno KJ, Cunningham FG. Subclinical hypotyroidism and Pregnancy Outcomes. The American College of Obstetricians and Gynecologists 2005; 2: 239-245. Go to original source...
  20. Fatourechi V. Subclinical hypothyroidism an update for primary care. Mayo Clin Proc. 2009; 84(1): 65-71. Go to original source...
  21. Fatourechi V. Subclinical hypothyroidism: how should it be managed? Treat Endocrinol. 2002; 1(4): 211-216. Go to original source... Go to PubMed...
  22. Karmisholt JS, Andersen S, Laurberg P. Variation in thyroid function in subclinical hypothyroidism. Importance for clinical follow-up and therapy. Eur J Endocrinol. 2011 Jan 5. Go to original source... Go to PubMed...
  23. Hekimsoy Z, Kafesçiler S, Güçlü F, Ozmen B. The prevalence of hyperprolactinemia in overt and subclinical hypothyroidism. Endocr J. Oct. 2010; 57(12): 1011-1015. Go to original source... Go to PubMed...
  24. Demartini B, Masu A, Scarone S, Pontiroli AE, Gambini O. Prevalence of depression in patients affected by subclinical hypothyroidism, Panminerva Med. 2010; 52(4): 277-282. Go to PubMed...
  25. Haddow JE, Palomaki GEAllan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341: 549-555. Go to original source... Go to PubMed...
  26. Meier C, Strub JJ, Roth CB, et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypoyroidism: a double blind, placebo controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab 2001; 86: 4860-4866. Go to original source... Go to PubMed...
  27. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Winter PA, MC Dermott MT. Consensus Statement: Subclinical Thyroid Dysfunctiuon: A Joint Statement on Management from the American Association of Clinical Endocrinologist, the American Thyroid Association, and The Endocrine Society. J Clin Endocr Metab 2005; 90(1): 581-585. Go to original source... Go to PubMed...
  28. Surks MI. Commentary: Subclinical Thyroid Dysfunctiuon: A Joint Statement on Management from the American Association of Clinical Endocrinologist, the American Thyroid Association, and The Endocrine Society. J Clin Endocr Metab 2005; 90(1): 586-587. Go to original source...
  29. Schouten BJ, Brownlie BE, Frampton CM, Turner JG. Subclinical thyrotoxicosis in an outpatient population - predictors of outcome Clin Endocrinol (Oxf). 2011; 74(2): 257-261. Go to original source... Go to PubMed...
  30. Ceresini G, Morganti S, Maggio M. Subclinical thyroid disease in eldery subject. Acta Biomed. 2010, 81(Suppl 1): 31-36.
  31. Zaidi M, Davies TF, Zallone A, Blair HC, Iqbal J, Moonga SS, Mechanick J, Sun L. Thyroid-stimulating hormone, thyroid hormones, and bone loss. Curr Osteoporos Rep. 2009; 7(2): 47-52. Go to original source... Go to PubMed...
  32. Parle JV, Maisonneuve P, Sheppard MC. Prediction of allcause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001; 358: 861-865. Go to original source... Go to PubMed...
  33. Biondi B, Palmieri EA, Klain M, Schlumberger M, Filetti S, Lombardi G. Subclinical hyperthyroidism: Clinical features and treatement options. Eurropean Journal of Endocronologists 2005; 152: 1-9. Go to original source... Go to PubMed...
  34. Ladenson PW. Tyrotoxicosis and the heart: old and something new. J Clin Endocrin Metab 1993; 77: 332-333. Go to original source...
  35. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin contrencation as a risk factor for atrial fibrilation in older person. N. Engl. J. Med. 1994; 331: 1249-1252. Go to original source... Go to PubMed...
  36. Faber J, Jensen IW, Petersen L, et al. Normalization of serum thyreotropin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopauzal women. Clin Endocrinol (Oxf). 1998; 48: 285-290. Go to original source... Go to PubMed...
  37. Lee JS, Buzková P, Fink HA. Subclinical thyroid dysfunction and incident hip fracture in older adults. Arch Intern Med. 2010; 170(21): 1876-1883. Go to original source... Go to PubMed...
  38. Eftekhari M, Asadollahi A, Beiki D. The long term effect of levothyroxine on bone mineral density in patients with well differentiated thyroid carcinoma after treatment. Hell J Nucl Med. 2008; 11(3): 160-163.
  39. Bauer DC, Ettinger B, Nevitt M, Stone KL. For the Study of Osteoporotic Fracture Research Group. Risk for fracture in women with low serum levels of thyroid stimulating hormone, Ann Inter Med. 2001; 134: 561-568. Go to original source... Go to PubMed...
  40. Tauchmanova L, Nizzo V, Fonderico F, Punte AED, Padulla S, Rossi A, Bifulco G, Lupoli G, Lombardi G. Reduced bone mass detected by bone quantitative ultrasonometry and DEXA in pre- and postmenopausal women with endogenous subclinical hyperthyroidism. Maturitas 2004; 3: 299-306. Go to original source... Go to PubMed...
  41. Kalmijn S, Mehta KM, Pols HAP, Hofman A, Drexhage HA, Breteler MMB. Subclinical hypertyroidism and the risk of dementia. The Rotterdam study. Clin. Endocrin. (Oxf.) 2000; 53: 733-737. Go to original source... Go to PubMed...
  42. Col NF, Surks MI, Daniels GH. Subclinical Thyroid Disease. JAMA 2004; 291: 239-243. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.